BRCA1 and cancer: Each of the groups displayed different number of methylation changes, with BRCA1 epimutation carriers harboring the highest number of 5163 differently methylated CpG sites, germline mutation carriers 2473 CpG sites, and cancer free women, who developed cancer after follow up, 12 CpG sites.